The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission
Open accessAbstract
Objective: To assess whether radiologic progression occurs during clinical remission in patients with rheumatoid arthritis (RA). Methods: One hundred eighty‐seven patients with RA in clinical remission were followed up clinically and radiologically for 2 years. Clinical remission was defined according to a modification of the American College of Rheumatology criteria (i.e., the criterion of fatigue was omitted, and patients had to fulfill 4 of the 5 remaining criteria). Radiologic joint damage was assessed by the Sharp/van der Heijde method. Results: After 2 years of followup, remission persisted in 52% of patients. The median radiologic score for the total group of patients increased from 21 (interquartile range [IQR] 5, 65) at the time of entry to 25 (IQR 7, 72) after 2 years (P < 0.001). The median score for radiologic progression between baseline and 2 years was 0.5 (IQR 0, 2.5). Among patients with an exacerbation of RA (n = 86), the median score for progression over 2 years was 1.0 (IQR 0, 4.5) (P < 0.001), and in patients with a persistent remission (n = 93) it was 0 (IQR −0.5, 2.0) (P < 0.001). Clinically relevant progression of damage was more frequent in patients with exacerbation (23%) than in those with persistent remission (7%) (P = 0.001). However, in 15% of patients with persistent remission, an erosion developed in a previously unaffected joint. In the logistic regression analysis, the area under the curve of the Disease Activity Score, a continuous measure, was related to the chance of radiologic progression, regardless of the absolute disease activity level. Results were similar when other definitions of remission were used. Conclusion: Although rare, clinically relevant progression of joint damage does occur in patients with RA in prolonged remission. This suggests the need for markers that predict progression during periods of low disease activity and for drugs that prevent damage that is independent of disease activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Gregersen, P. K., Silver, J., & Winchester, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,599
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Chernoff, M., Fried, B., Furst, D., Goldsmith, C., Kieszak, S., Lightfoot, R., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360601 · Cited by 1,640
Self-citation(1968) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067150 · Cited by 1,349
INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Ipsky, P. E. E. L., Illiam, E. W., Urst, D. A. E. F., Reedveld, C. B., Oachim, J., Alden, R. K., Osef, J., Molen, S. S., Eisman, M. I. W., Mery, P. A. E., et al. (2000) · Cited by 1,155
van der Heijde, D. M., van 't Hof, M. A., van Riel, P. L., Theunisse, L. A., Lubberts, E. W., van Leeuwen, M. A., van Rijswijk, M. H., & van de Putte, L. B. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.11.916 · Cited by 1,087
Boers, M., Verhoeven, A. C., Markusse, H. M., van de Laar, M. A., Westhovens, R., van Denderen, J. C., van Zeben, D., Dijkmans, B. A., Peeters, A. J., Jacobs, P., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01300-7 · Cited by 1,073
Self-citationPreliminary criteria for clinical remission in rheumatoid arthritis
Pinals, R. S., Masi, A. T., & Larsen, R. A. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780241012 · Cited by 803
Van Der Heijde, D., Van Riel, P., Gribnau, F., Nuver-Zwart, I., & Van De Putte, L. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92442-2 · Cited by 556
Synovial tissue macrophage populations and articular damage in rheumatoid arthritis
Mulherin, D., Fitzgerald, O., & Bresnihan, B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390116 · Cited by 515
Felson, D. T., Anderson, J. J., Lange, M. L. M., Wells, G., & LaValley, M. P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 474
PREVOO, M. L. L., VAN GESTEL, A. M., VAN THOF, M. A., VAN RIJSWIJK, M. H., VAN DE PUTTE, L. B. A., & VAN RIEL, P. L. C. M. (1996) · Rheumatology · doi:10.1093/rheumatology/35.11.1101 · Cited by 373
Mulherin, D. (1996) · Rheumatology · doi:10.1093/rheumatology/35.12.1263 · Cited by 226
Measurement of disability in Dutch rheumatoid arthritis patients
Siegert, C. E. H., Vleming, L. J., Van-Denbroucke, J. P., & Cats, A. (1984) · Clinical Rheumatology · doi:10.1007/bf02032335 · Cited by 185
Garnero, P., Landewé, R., Boers, M., Verhoeven, A., Van Der Linden, S., Christgau, S., Van Der Heijde, D., Boonen, A., & Geusens, P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10616 · Cited by 182
Self-citationRandomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis
ten Wolde, S., Breedveld, F. C., Dijkmans, B. A. C., Hermans, J., Vandenbroucke, J. P., van de Laar, M. A. F. J., Markusse, H. M., Janssen, M., & van den Brink, H. R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90535-8 · Cited by 161
Self-citationFactors predicting outcome of rheumatoid arthritis: results of a followup study.
van Zeben, D., Hazes, J. M. W., Zwinderman, A. H., Vandenbroucke, J. P., & Fc, B. (1993) · PubMed · Cited by 161
NATURAL REMISSION IN INFLAMMATORY POLYARTHRITIS: ISSUES OF DEFINITION AND PREDICTION
Harrison, B., Symmons, D. P. M., Brennan, P., Barrett, E. M., & Silman, A. J. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/35.11.1096 · Cited by 129
The relationship between synovitis and erosions in rheumatoid arthritis
Kirwan, J. (1997) · Lara D. Veeken · doi:10.1093/rheumatology/36.2.225 · Cited by 86
Course and Prognosis of Early Rheumatoid Arthritis
Rasker, J. J., & Cosh, J. (1989) · Scandinavian Journal of Rheumatology · doi:10.3109/03009748909092612 · Cited by 33
Molenaar, E. (2000) · British journal of rheumatology · doi:10.1093/rheumatology/39.7.742 · Cited by 24
Self-citation
Cited by
Treating rheumatoid arthritis to target: recommendations of an international task force
Smolen, J. S., Aletaha, D., Bijlsma, J. W. J., Breedveld, F. C., Boumpas, D., Burmester, G., Combe, B., Cutolo, M., de Wit, M., Dougados, M., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.123919 · Cited by 2,100
Smolen, J. S., Breedveld, F. C., Burmester, G. R., Bykerk, V., Dougados, M., Emery, P., Kvien, T. K., Navarro-Compán, M. V., Oliver, S., Schoels, M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207524 · Cited by 1,465
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Schett, G., & Gravallese, E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.153 · Cited by 947
Brown, A. K., Conaghan, P. G., Karim, Z., Quinn, M. A., Ikeda, K., Peterfy, C. G., Hensor, E., Wakefield, R. J., O'Connor, P. J., & Emery, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23945 · Cited by 785
Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states
Aletaha, D., Ward, M. M., Machold, K. P., Nell, V. P. K., Stamm, T., & Smolen, J. S. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21235 · Cited by 542
Metadata
- Authors
- Molenaar, E. T. H., Voskuyl, A. E., Dinant, H. J., Bezemer, P. D., Boers, M., & Dijkmans, B. A. C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 50
- Issue
- 1
- Pages
- 36-42
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2066357843
- Cited by
- 384
- References
- 25
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.